Network Medicine Institute
The Network Medicine Institute (NMI) is a nonprofit with entities recognized by the United States and European Union. Its mission is to provide resources and guidance to alliance members so their research can have a global impact on health policy and clinical guidelines and untap the full potential of personalized medicine.
EXECUTIVE TEAM
Prof. Joseph Loscalzo
NMI Chairman and Scientific Committee Chair
Hersey Professor of the Theory and Practice of Medicine at Harvard University, Soma Weiss M.D., Distinguished Chair in Medicine Harvard Medical School, Chairman of the Department of Medicine, and Physician-in-Chief at Brigham and Women’s Hospital, Harvard University, USA
Enrico Petrillo, MD
NMI Executive Director and Board Member
Advisor to the Chairman, Dept. of Medicine, and Physician–in–Chief for International Research, Lead Investigator at Brigham and Women’s Hospital Division of General Internal Medicine, Lecturer Harvard Medical School, Harvard University, faculty researcher at Karolinska Institute, Sweden.
Andrei Bezdedeanu
Advisor, Data Analytics and Science
Andrei is a seasoned technology leader with over 20 years of experience designing and building solutions to solve complex problems in Financial Services and Cybersecurity. Andrei has a Master’s in Computer Science from Tufts University and an accomplished record of building software platforms for research, analysis, and decision making. His experience includes serving as Head of Application Development at global asset management firms, Vice President of Engineering at a global leading edge cybersecurity technology company, member of Executive Leadership Teams and Board of Directors, speaker at national conferences and recognized technology thought leader.
Michael Fritz
Director, Institutional Development
Michael is establishing US operations for the Network Medicine Institute. This includes supporting high priority projects such as the COVID-19 Global Drug Repurposing Study. He was previously a venture investor in breakthrough Healthcare IT companies at Excel Venture Management. Before that he was a management consultant at the Parthenon Group (since acquired by Ernst and Young) where he worked with healthcare, technology, and private equity clients. He also founded TalentList.ai and has a degree in engineering and economics from Dartmouth College.
Attorney Donato Cicenia, Board Member and Institute Legal Counsel
GOALS
Provide leverage for funding research, influencing global health policy, and updating clinical guidelines
Maintain a scientific committee composed of representatives from the Alliance's Universities and Institutes
Maintain an advisory group to develop and implement fundraising strategies for breakthrough research
Provide guidance about how to obtain funding as part of the alliance grant proposal process and how to prioritize research objectives to have a global impact on health policy and clinical guidelines
Strategy
Identify alliance funding contacts and resources (already in place and to be applied for)
Educate key constituencies around the world such as Governments, Ministries, and Foundations
Raise awareness and promote the alliance’s unique capabilities to attract funding and resources to high priority projects
Develop a series of white papers to help influence global health policy, clinical guidelines, and resource allocations set by key constituencies such as the EU, National Ministries, US Government, and other Foundations
Fundraising
The Institute will help alliance members prioritize funding sources and submit proposals. Potential funding sources include but not limited to:
› Global Foundations and Corporations
› National Ministries of Health and Research
› United States National Institutes of Health
› European Union
› International Philanthropic Foundations
› United Nations: WHO & UNESCO
› European Innovative Medicines Initiative
Impact
The Institute and Alliance provide an open platform connecting the world’s preeminent medical researchers and helping them develop meaningful partnerships with public and private institutions.
Collaborative and well funded interdisciplinary research on a global scale holds great promise for global heath by untapping the full potential of Personalized Medicine.